Publication
TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
Authors not recorded
J Am Acad Dermatol2014PMID 25219713stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (3)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 3
- cancerAcral Lentiginous Melanomacivic_curation1.00
- geneTERTcivic_curation1.00
- variantTERT Amplificationcivic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25219713
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| TERT Amplification1 | ||||||||
| (prognostic) | Acral Lentiginous Melanoma | Prognostic | B | Supports Poor Outcome | 3 | accepted | EID514In patients with acral lentiginous melanoma, those with amplification of TERT had shorter overall survival. PMID 25219713 · Diaz et al., 2014 · Open in CIViC | civic |